Ykrita Life Sciences

About:

YLS develops a medical device to help clinicians treat patients without the need for an organ transplant & hospitalisation.

Website: https://ykrita.com

Top Investors: Venture Catalysts, Turbostart, Indian Scientific Innovation Company

Description:

YLS is developing a bio-medical device: Bio-engineered Artificial Ectopic Liver (BAEL), aimed at helping clinicians to treat patients suffering from liver failure while eliminating the need for an organ transplant, hospitalization, and exorbitant expenditure on the treatment.